Phenotypic differences between IgG4+ and IgG1+ B cells point to distinct regulation of the IgG4 response - 25/12/13
Doi : 10.1016/j.jaci.2013.07.044
Laura C. Lighaam, MSc a, b, Ellen Vermeulen, BSc a, b, Tamara den Bleker, BSc a, b, Kimberley J. Meijlink, BSc a, b, Rob C. Aalberse, PhD a, b, Eleanor Barnes, PhD c, Emma L. Culver, MD c, S. Marieke van Ham, PhD a, b, Theo Rispens, PhD a, b 
a Sanquin Blood Supply, Division of Research, Amsterdam, The Netherlands
b Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
c Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom
| Disclosure of potential conflict of interest: E. Barnes and E. L. Culver have received a grant from the Wellcome Trust. S. M. van Ham is employed by Sanquin Blood Supply, has provided expert testimony for the RIVM Strategic Vaccine Committee, has received grants from LSBR, and has a patent pending for a newly developed maturation cocktail for immature monocyte-derived dendritic cells using a cocktail of MPLA and IFNg. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2013
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 133 - N° 1
P. 267 - janvier 2014 Retour au numéro
Article précédent
- Successful cure of C1q deficiency in human subjects treated with hematopoietic stem cell transplantation
- Peter D. Arkwright, Philip Riley, Stephen M. Hughes, Hana Alachkar, Robert F. Wynn
- Sphingomyelin and ceramide are physiological ligands for human LMIR3/CD300f, inhibiting Fc?RI-mediated mast cell activation
- Kumi Izawa, Masamichi Isobe, Toshihiro Matsukawa, Shinichi Ito, Akie Maehara, Mariko Takahashi, Yoshinori Yamanishi, Ayako Kaitani, Toshihiko Oki, Ko Okumura, Toshio Kitamura, Jiro Kitaura
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?